skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8847

Determination of RBC membrane and serum lipid composition in trinidadian type II diabetics with and without nephropathy

Original Research

(2445) Views  (718) Full article downloads

Authors: B Shivananda Nayak, Vishi Y Beharry, Shivani Armoogam, Melinda Nancoo, Kevin Ramadhin, et al

Published Date September 2008 Volume 2008:4(4) Pages 893 - 899
DOI: http://dx.doi.org/10.2147/VHRM.S2656

B Shivananda Nayak1, Vishi Y Beharry1, Shivani Armoogam1, Melinda Nancoo1, Kevin Ramadhin1, Kiron Ramesar1, Ciara Ramnarine1, Anandi Singh1, Anisha Singh1, Kingsley Uche Nwachi1, Surujpaul Teelucksing2, Ramesh Mathura3, Lesley Roberts4

1Department of Preclinical Sciences, Biochemistry Unit, 2Department of Clinical Science, The University of the West Indies, EWMSC, Trinidad and Tobago; 3Department of Diagnostic Laboratory Services, NCRHA, EWMSC, Trinidad and Tobago; 4Department of Medicine, Nephrology Unit, NCRHA, EWMSC, Trinidad and Tobago

Aim: The rheological properties of erythrocytes are impaired in diabetes mellitus, especially because of changes in their membrane lipid composition.The aim of this study was to determine and examine the relationship between red blood cell (RBC) membrane and serum lipid composition in type II diabetes subjects with and without nephropathy.

Methods: Trinidadian subjects aged 18–65 years were recruited for the study regardless of gender and ethnicity. Fasting blood samples were collected from 60 subjects of whom 20 were healthy individuals, 20 had type II diabetes without complications, and 20 were type II diabetics with nephropathy. Weight, height, waist/hip ratio, and blood pressure were recorded. All the blood samples were analysed to determine the serum lipid concentration, membrane lipid composition and plasma glucose concentration.

Results: The body mass index and the systolic blood pressure of the diabetics (28.17 ± 4.98 kg/m2, 153.21 ± 22.10 mmHg) and those with nephropathy (25.87 ± 4.68, 158.60 ± 22.49 mmHg) were higher when compared with controls (24.67 ± 5.18, 119.15 ± 13.03 mmHg). The diabetic (175.89 ± 102.73 μg/mgprotein) and diabetic nephropathy (358.80 ± 262.66) subjects showed significantly higher levels of RBC membrane cholesterol compared with controls (132.27 ± 66.47). The membrane phospholipids, protein and Na+/K+ATPase concentrations were altered in diabetics and diabetic nephropathy patients when compared with controls. The trends of increased serum cholesterol and decreased high-density lipoprotein in diabetics and diabetic nephropathy patients were noted as compared with controls but they are not significant as expected. The low-density lipoprotein cholesterol was significantly higher in diabetics when compared with diabetic nephropathy and control subjects.

Conclusions: Our data suggest that there is a relationship between RBC membrane and serum lipid composition in subjects with type II diabetes with and without nephropathy. This relationship shows that diet and lifestyle plays a significant role in the alterations of the lipids both in serum and RBC membrane. The membrane and serum lipid composition may be used as possible indicators for type II diabetic patients with and without nephropathy to control their diet in the beginning stages to prevent them from further complications.

Keywords: RBC membrane, phospholipids, protein, diabetes, diabetic nephropathy






 

Other articles by Dr Shivnanda Nayak



Readers of this article also read:

Urotensin II in cardiovascular regulation
Is continuous insulin treatment safe in aneurysmal subarachnoid hemorrhage?
Manifestation of renal disease in obesity: pathophysiology of obesity-related dysfunction of the kidney
Effect of antiretroviral drugs on the pharmacodynamics of gliclazide with respect to glucose–insulin homeostasis in animal models
Potential antidiabetic and antioxidant activities of Morus indica and Asystasia gangetica in alloxan-induced diabetes mellitus
Nephroprotective action of glycosaminoglycans: why the pharmacological properties of sulodexide might be reconsidered
Angiotensin (1-7)/Mas receptor axis activation ameliorates the changes in fatty acid composition in diabetic rats with nephropathy
New and improved strategies for the treatment of gout
Diabetic microvascular complications: possible targets for improved macrovascular outcomes
Role of aliskiren in blood pressure control and renoprotection
  • Join ISVH

    Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)

  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University